Hedge Fund - Solas Capital Management

Fennec Pharmaceuticals Inc. (FENC) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $13,708,097 7.71% 2,250,919 $6.42
2 2024 - Q4 (2024-12-31) $14,225,808 9.44% 2,250,919 $5.12
3 2024 - Q3 (2024-09-30) $9,617,680 6.75% 1,923,536 $5.78
4 2024 - Q2 (2024-06-30) $8,187,400 4.47% 1,340,000 $8.30
5 2024 - Q1 (2024-03-31) $12,345,791 7.93% 1,110,233 $10.04
6 2023 - Q4 (2023-12-31) $15,466,916 9.6% 1,378,513 $8.28
7 2023 - Q3 (2023-09-30) $12,959,008 9.06% 1,725,567 $8.14
8 2023 - Q2 (2023-06-30) $12,706,617 8.45% 1,439,028 $8.31
9 2023 - Q1 (2023-03-31) $10,687,398 5.7% 1,284,543 $9.27
10 2022 - Q4 (2022-12-31) $12,022,925 7.21% 1,252,388 $8.85
11 2022 - Q3 (2022-09-30) $9,162,000 5.58% 1,131,167 $6.86
12 2022 - Q2 (2022-06-30) $6,548,000 3.9% 1,173,516 $5.80
13 2022 - Q1 (2022-03-31) $6,416,000 3.88% 1,145,796 $5.04
14 2021 - Q4 (2021-12-31) $3,819,000 2.72% 867,857 $7.44
15 2021 - Q3 (2021-09-30) $8,175,000 5.68% 867,857 $7.50
16 2021 - Q2 (2021-06-30) $6,327,000 4.43% 867,857 $6.67
17 2021 - Q1 (2021-03-31) $4,968,000 4.17% 800,000 $7.53
18 2020 - Q4 (2020-12-31) $5,960,000 4.54% 800,000 $7.62
19 2020 - Q3 (2020-09-30) $4,848,000 4.64% 800,000 $7.05
20 2020 - Q2 (2020-06-30) $8,016,000 7.39% 960,000 $7.44
21 2020 - Q1 (2020-03-31) $5,702,000 6.17% 960,000 $6.52
22 2019 - Q4 (2019-12-31) $6,307,000 6.06% 971,795 $5.37
23 2019 - Q3 (2019-09-30) $4,537,000 4.69% 943,200 $4.41
24 2019 - Q2 (2019-06-30) $3,400,000 3.47% 849,979 $4.23

The displayed share prices are average quarterly stock market prices.

The share numbers are adjusted according to following stock splits:

  1. 1.0000:3.0000 on 2014-09-09

  2. 1.0000:18.0000 on 2011-08-31